Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present AngioDynamics, Inc. (NASDAQ: ANGO).

Full DD Report for ANGO

You must become a subscriber to view this report.


Recent News from (NASDAQ: ANGO)

AngioDynamics Q1 non-GAAP EPS up 23%
AngioDynamics ( ANGO ) Q1 results : Revenues: $85.3M (-0.1%). More news on: AngioDynamics, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...
Source: SeekingAlpha
Date: September, 27 2018 07:24
AngioDynamics misses by $0.02, beats on revenue
AngioDynamics (NASDAQ: ANGO ): Q1 Non-GAAP EPS of $0.16 misses by $0.02 ; GAAP EPS of -$0.01. More news on: AngioDynamics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: September, 27 2018 07:01
AngioDynamics Reports Fiscal 2019 First Quarter Financial Results
Fiscal 2019 First Quarter Highlights Net sales of $85.3 million, flat versus prior year Gross margin expanded 380 basis points year over year to 52.1% GAAP EPS of $(0.01) per share; adjusted EPS of $0.16 per share Cash used in operations of $8.9 million; capital e...
Source: Business Wire
Date: September, 27 2018 07:00
AngioDynamics (ANGO) Presents at 2018 Wells Fargo Securities Healthcare Conference - Slideshow
The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more ...
Source: SeekingAlpha
Date: September, 06 2018 15:21
I Got 43% Return On My Obesity-Themed Portfolio. Janus Henderson Investors Did Better With SLIM.
Hey, lookit dat! I can make a comparison! I had an epiphany. In my last article I shot my mouth off about not having made any comparisons of the non-neg Efficient Frontier ((EF)) process against other methods. While strictly true, maybe that intent can be approached by comparing my Mot...
Source: SeekingAlpha
Date: August, 27 2018 11:39
AngioDynamics to Present at Two Investor Conferences in September
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today announced that it will present at the following two investor conferences in September: A live webcast of each ...
Source: Business Wire
Date: August, 23 2018 16:01
Factors of Influence in 2018, Key Indicators and Opportunity within Okta, Great Lakes Dredge & Dock, MDC Partners, Colfax, Heritage-Crystal Clean, and AngioDynamics - New Research Emphasizes Economic Growth
NEW YORK, Aug. 17, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Okta, Inc. (NASDAQ:OKTA), Great Lakes Dredge & Dock Corporation (NASD...
Source: GlobeNewswire
Date: August, 17 2018 07:55
FDA streamlines voluntary device malfunction reporting
The FDA has finalized its program for device makers for the voluntary reporting of device malfunctions. Manufacturers will be allowed to report certain product glitches on a quarterly basis and in summary form for certain product codes, reducing the number of required reports by about two ...
Source: SeekingAlpha
Date: August, 16 2018 10:22
AngioDynamics acquires sealant system using in lung biopsies
AngioDynamics (NASDAQ: ANGO ) acquires the BioSentry Track Sealant System from privately held Surgical Specialties, LLC for an undisclosed sum. The product is used to minimize the occurrence of pneumothorax (collapsed lung), a common complication of CT-guided percutaneous lung biopsy. Mo...
Source: SeekingAlpha
Date: August, 15 2018 07:39
AngioDynamics Provides Updates on Oncology and Vascular Access Businesses
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today provided a corporate update on enhancements made to its Oncology business and acknowledged a recent, favorable U.S. Di...
Source: Business Wire
Date: August, 15 2018 07:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0823.7223.6923.8423.40209,525
2018-05-1719.8019.7719.9819.63211,581
2017-06-2016.3116.1716.409915.97189,802
2017-06-1916.0016.2816.3715.94187,884
2017-06-1615.6315.9715.9815.62308,029

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-113,92110,33137.9537Short
2018-12-105,4818,71062.9277Short
2018-12-0736,37794,89238.3352Short
2018-12-0622,81491,51424.9295Cover
2018-12-0413,97627,99649.9214Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ANGO.


About AngioDynamics, Inc. (NASDAQ: ANGO)

Logo for AngioDynamics, Inc. (NASDAQ: ANGO)

Not available

 

Contact Information

 

 

Current Management

  • Eamonn P. Hobbs / President, CEO
  • Joseph G. Gerardi / CFO

Current Share Structure

  • Market Cap: $723,208,543 - 05/14/2018
  • Issue and Outstanding: 36,804,506 - 04/03/2018

 


Recent Filings from (NASDAQ: ANGO)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: April, 05 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 29 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 29 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 09 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: February, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 24 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: January, 19 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 10 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: January, 05 2018

 

 


Daily Technical Chart for (NASDAQ: ANGO)

Daily Technical Chart for (NASDAQ: ANGO)


Stay tuned for daily updates and more on (NASDAQ: ANGO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ANGO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ANGO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ANGO and does not buy, sell, or trade any shares of ANGO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/